Global Beta Glucan Market 2022 - Industry Briefing

According to , the global beta glucan market is set to achieve an incremental growth of USD 215.7 million, acelerating at a CAGR of almost 6.7% during the forecast period 2022-2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product type, source, end user, and region. The global market data on beta glucan can be segmented by product type: insoluble, soluble. The soluble segment held the largest share of the global beta glucan market in 2021 and is anticipated to hold its share during the forecast period. Beta glucan market is further segmented by source: cereals, fungi, others. Based on end user, the beta glucan market is segmented into: food & beverages, nutraceutical supplements, others. The nutraceutical supplements segment was the largest contributor to the global beta glucan market in 2021. On the basis of region, the beta glucan market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The food & beverages market is further segmented into baked goods, beverages, confectionery, dairy, snacks, others. In 2021, the dairy segment made up the largest share of revenue generated by the beta glucan market. Furthermore, the nutraceutical supplements market has been categorized into dietary supplements, infant nutrition. Among these, the dietary supplements segment was accounted for the highest revenue generator in 2021.

The global beta glucan market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Ceapro Inc., Givaudan SA, Kemin Industries Inc., Kerry Group plc, Koninklijke DSM N.V. (Oatwell), Lallemand Inc. (Biotec BetaGlucans AS), Lantmannen Group, Ohly GmbH (ABF Ingredients Ltd.), Phileo by Lesaffre (Lesaffre Corporation), Super Beta Glucan (SBG) Inc., Vesta Pharmaceuticals Inc., Yaizu Suisankagaku Industry Co. Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
- Get a detailed picture of the Global Beta Glucan Market
- Identify segments/areas to invest in over the forecast period in the Global Beta Glucan Market
- Understand the competitive environment, the markets leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.

Part 1. Summary

Part 2. Introduction
Study period
Geographical scope
Market segmentation

Part 3. Beta glucan market overview

Part 4. Market breakdown by product type

Part 5. Market breakdown by source

Part 6. Market breakdown by end user
Food & beverages
Nutraceutical supplements

Part 7. Market breakdown by region
Asia Pacific
North America
Rest of the World (RoW)

Part 8. Key companies
Ceapro Inc.
Givaudan SA
Kemin Industries, Inc.
Kerry Group plc
Koninklijke DSM N.V. (Oatwell)
Lallemand Inc. (Biotec BetaGlucans AS)
Lantmannen Group
Ohly GmbH (ABF Ingredients Ltd.)
Phileo by Lesaffre (Lesaffre Corporation)
Super Beta Glucan (SBG) Inc.
Vesta Pharmaceuticals, Inc.
Yaizu Suisankagaku Industry Co., Ltd.

Part 9. Methodology

Global Sea Bass Market 2022 - Industry Briefing

The global sea bass market is anticipated to increase by USD 1.4 billion till 2028 at an average annual growth of 6.1 percent as per the latest report.This industry report

USD 850 View Report

Global Protein Alternatives Market 2022-2028

The global protein alternatives market is anticipated to increase by USD 4.9 billion till 2028 at an average annual growth of 6.7 percent as per the latest report by .The

USD 2600 View Report

Global Beta-Alanine Market Research Report 2021-2025

Beta-Alanine is a naturally occurring beta amino acid, which is an amino acid in which the amino group is at the -position from the carboxylate group. In the context of

USD 3200 View Report

1,3 Beta Glucan Synthase (EC - Drugs in Development, 2021

1,3 Beta Glucan Synthase (EC - Drugs in Development, 20211,3 Beta Glucan Synthase (EC - Drugs in Development, 2021 provides in depth analysis on 1,3 Beta Glucan Synthase

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available